13 September 2020>: Clinical Research
Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB)Fei Yan BCDE , Zihong Wu BCD , Zihui Li ABCD , Li Liu BCDE*
Med Sci Monit 2020; 26:e922814
Figure 1 The effect of celastrol on viability of TNBC cells. (A, B) Cell viability was examined in MDA-MB-231 and MDA-MB-468 cells after exposure to various doses of celastrol for 24 h via MTT assay. * P<0.05 vs. the non-treated group (0 μM).